Fineotex Chemical Files Q3FY26 Monitoring Report with Revised Proceeds Data

2 min read     Updated on 13 Feb 2026, 10:48 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Fineotex Chemical submitted its Q3FY26 monitoring agency report revealing significant revision in proceeds from INR 280.350 crores to INR 91.963 crores due to preferential issue undersubscription in May 2024. ICRA Limited confirmed proper utilization of INR 56.282 crores across stated objectives with no material deviations, while INR 35.682 crores remains invested in mutual funds.

32548693

*this image is generated using AI for illustrative purposes only.

Fineotex Chemical Limited has submitted its quarterly monitoring agency report for Q3FY26 to the Bombay Stock Exchange and National Stock Exchange, providing updated details on the utilization of proceeds raised through its preferential issue completed in May 2024.

Issue Details and Revised Proceeds Status

The specialty chemicals company originally planned to raise INR 280.350 crores through a preferential issue of equity shares and convertible warrants during May 13-22, 2024. However, due to undersubscription, the actual net proceeds were revised downwards to INR 91.963 crores.

Parameter Details
Original Issue Size INR 280.350 crores
Revised Issue Size INR 91.963 crores
Issue Type Preferential Issue (Equity Shares & Convertible Warrants)
Issue Period May 13-22, 2024
Warrants Exercised 13,75,000 out of 26,26,600 allotted
Forfeited Warrants 12,51,600 warrants

Monitoring Agency Assessment

ICRA Limited, appointed as the monitoring agency, confirmed that the utilization of issue proceeds remains in line with the stated objects of the issue. The report indicates no material deviations from the original plan disclosed in the offer document.

Compliance Parameter Status Agency Comments
Utilization as per Offer Document Yes Cost of objects revised downwards pro-rata due to undersubscription
Material Deviations Not Applicable No comments
Means of Finance Changes No No comments
Major Deviations from Earlier Reports No No comments

Revised Proceeds Utilization Breakdown

The company has allocated the available proceeds across three primary objectives with costs revised proportionally due to undersubscription:

Object Original Allocation (INR Crores) Revised Allocation (INR Crores) Utilized (INR Crores) Unutilized (INR Crores)
Working Capital Requirement 50.000 16.402 - 16.402
Business Expansion 161.000 52.813 46.497 6.316
General Corporate Purposes 69.350 22.749 9.785 12.964
Total 280.350 91.963 56.282 35.681

General Corporate Purpose Utilization

The report provides specific details on how general corporate purpose funds totaling INR 9.785 crores have been utilized across different quarters:

Expense Category Amount (INR Crores) Quarter
Stock Exchange Fees & Issue Expenses 0.195 Q2FY2025
Advisory & Professional Services 9.104 Q2FY2025
Depository & Professional Fees 0.103 Q3FY2025
Travelling Expenses 0.379 Q3FY2025
Other Maintenance Expenses 0.004 Q3FY2025

Investment of Unutilized Proceeds

The company has deployed INR 35.682 crores of unutilized proceeds in mutual fund investments, generating returns of INR 0.186 crores with a market value of INR 35.867 crores as of quarter-end.

Implementation Timeline

All objects remain on schedule with completion targeted by September 30, 2030. The monitoring agency found no delays in implementation across any of the stated objectives despite the significant reduction in proceeds due to undersubscription.

The monitoring agency report emphasizes that it does not constitute commentary on the quality of issue objects or assurance on spending outcomes, but provides an objective view of proceeds utilization based on information provided by the issuer.

Historical Stock Returns for Fineotex Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.96%-8.09%-4.82%-8.40%-8.52%+222.44%

Fineotex Chemical Allots 50 Lakh Shares at ₹38.74 Each Following Warrant Conversion

2 min read     Updated on 19 Jan 2026, 09:14 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Fineotex Chemical Limited has successfully completed the allotment of 50 lakh equity shares at ₹38.74 per share following warrant conversion by non-promoter investor Intuitive Alpha Investment Fund PCC - Cell 1. The January 17, 2026 allotment generated ₹14.52 crore for the company and expanded its paid-up share capital to ₹116.45 crore. The shareholding structure now stands at 61.87% for promoters and 38.13% for non-promoters, while 23.15 lakh unexercised warrants worth ₹22.42 crore have been forfeited due to non-conversion within regulatory timelines.

30383056

*this image is generated using AI for illustrative purposes only.

Fineotex Chemical Limited has announced a substantial equity allotment following the successful conversion of warrants issued on a preferential basis. The specialty chemicals manufacturer completed the allotment of 50 lakh equity shares, marking a significant expansion in its share capital structure.

Major Equity Allotment Details

The Board's Fund Raising Committee authorized the equity allotment during its meeting held on January 17, 2026. The allotment specifics demonstrate the company's successful capital raising initiative:

Parameter: Details
Shares Allotted: 50 lakh equity shares
Face Value: ₹1.00 per share
Issue Price: ₹38.74 per share
Premium: ₹37.74 per share
Total Consideration: ₹14.52 crore

The allotment resulted from the conversion of 5 lakh warrants by Intuitive Alpha Investment Fund PCC - Cell 1, classified under the non-promoter category. The company received the remaining consideration of ₹14.52 crore, representing 75% of the warrant issue price, completing the conversion process.

Warrant Conversion Structure

The warrant conversion followed a structured payment mechanism established during the initial issuance. Each warrant carried specific financial terms that facilitated the conversion process:

Component: Amount per Warrant
Initial Issue Price: ₹387.40
Subscription Payment (25%): ₹96.85
Conversion Payment (75%): ₹290.55

The conversion terms were appropriately adjusted following the share split and bonus issue authorized by shareholders at the Extraordinary General Meeting held on October 25, 2025. The newly issued equity shares carry identical rights to existing shares, including voting and dividend entitlements.

Updated Capital Structure

Following the completion of this allotment, Fineotex Chemical Limited's financial structure has been significantly enhanced. The company's issued and paid-up share capital has expanded substantially:

Capital Component: Current Status
Total Paid-up Capital: ₹116.45 crore
Total Equity Shares: 116.45 crore shares
Face Value per Share: ₹1.00
Promoter Shareholding: 61.87%
Non-Promoter Shareholding: 38.13%

Outstanding Warrant Status

The company has also provided comprehensive details regarding the status of previously issued convertible warrants. Of the 28.15 lakh warrants originally issued on July 19, 2024, only 5 lakh warrants have been exercised to date.

Significantly, the remaining 23.15 lakh unexercised warrants have been forfeited in accordance with SEBI ICDR Regulations. The warrant holders failed to exercise their conversion rights within the stipulated 18-month timeframe, resulting in the forfeiture of approximately ₹22.42 crore in subscription proceeds.

Company Profile

Fineotex Chemical Limited operates as a leading manufacturer of specialized performance chemicals, serving diverse industrial sectors including textile, water treatment, oil and gas, and home care industries. The company maintains a global presence across more than 70 countries, supported by state-of-the-art production facilities located in India and Malaysia, focusing on innovation, sustainability, and performance excellence in international markets.

Historical Stock Returns for Fineotex Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.96%-8.09%-4.82%-8.40%-8.52%+222.44%

More News on Fineotex Chemical

1 Year Returns:-8.52%